Leniolisib for treating activated phosphoinositide 3-kinase delta syndrome in people 12 years and over

  • Highly specialised technologies guidance
  • HST33
  • Published: 
Download guidance (PDF)

6 Update information

October 2025: In section 2, the list price for leniolisib was updated.

ISBN: 978-1-4731-6939-5